Techsuvichar

Thursday, June 20, 2019

Earum IPO Date, Price, GMP, Review & Details

Incorporated in 2012, Ahmedabad-based Earum Pharmaceuticals Limited is engaged in trading, marketing, distribution of pharmaceutical formulation products. The company has 125 drugs formulation products including multivitamins, gynecology drugs, steroids, anti-biotic drugs, cerebral activator drugs, gastrointestinal drugs, etc. The company is also involved in the trading business of active pharmaceutical ingredients (API's) including Amoxicillin Trihydrate IP, Levofloxacin Hemihydrate IP, and Albendazole IP. Earum Pharmaceuticals is primarily engaged in two types of business activities; marketing of its own formulations products and trading of other brands' generic formulations. Currently, it has around 24 products which are manufactured by 3rd parties and marketed by the company under its brand name.It has a warehouse at Ahmedabad, Gujarat equipped with all amenities to process business operations smoothly. The company has a domestic and international presence across South East Asia, Latin America, and Africa.

Future goals of Earum Pharmaceuticals Ltd are:

1. Make global presence more prominent

2. Enhance customer satisfaction by improving market skills

3. Deal in quality standard products

The competitive strengths of the company are:

1. Wide product range

2. The experienced promoter of 11+ years experience

3. Quality assurance

Company Promoters:

Mr. Bhumishth Narendrabhai Patel and Mrs. Payal Bhumishth Patel are the promoters of the company.

Company Financials:

Summary of financial Information (Restated)

Particulars For the year/perio(d/d eefnadueltd.a s(pin) Rs. Lakhs)

31-Dec-18 31-Mar-18 31-Dec-17 31-Mar-16

Total Assets 2,741.00 2,052.88 1,108.45 878.71

Total Revenue 3,449.85 3,543.67 2,333.95 1,856.66

Profit After Tax 86.51 85.65 15.98 9.76

Objects of the Issue:

The company intends to utilize the proceeds of the Issue to meet the following objects:-

1. To meet Working Capital requirements

2. General Corporate Purpose

3. To meet issue expenses

Earum IPO Details

Issue Open Jun 21, 2019 - Jun 26, 2019

Issue Type Fixed Price Issue IPO

Issue Size 1,848,000 Eq Shares of Rs 10

(aggregating up to Rs 6.65 Cr)

Face Value Rs 10 Per Equity Share

Issue Price Rs 36 Per Equity Share

Market Lot 3000 Shares

Min Order Quantity 3000 Shares

Listing At BSE SME

Earum IPO Promoter Holding

Pre Issue Share Holding 100%

Post Issue Share Holding

Earum Pharmaceuticals Limited

G1, Ground Floor, V R Complex,

Near Sanathal Cross Road, SP Ring Road,

Sanathal, Ahmedabad, Gujarat-382210,

Phone: +91-79-48402525

Email: cs@earumpharma.com

Website: http://www.earumpharma.com

Bigshare Services Pvt Ltd

1st Floor, Bharat Tin Works Building,

Opp. Vasant Oasis,Makwana Road,

Marol, Andheri(E), Mumbai - 400 059

Phone: +91-22-6263 8200

Email: ipo@bigshareonline.com

Website: http://www.bigshareonline.com

Conclusion / Investment Strategy

EPL does not own manufacturing unit and is engaged in trading activities only. The issue is fully priced. Third-party contract business raises concern. Currently, the pharma sector is not fancied by investors. Merchant Banker has an average track record. Considering all these, investors may skip this issue.

Latest Share Market News, Latest Share News, Latest Share Market Tips, Latest Share Market Videos, Latest Share Market News In Hindi, Latest Share Recommendations , Latest Stock Market News, Latest Stock Market Recommendations , Latest Stock Market News India, Latest Stock News India, Latest Stock Picks, Latest Stock Market Analysis Market Watch, Latest Stock Market Videos

Monday, June 17, 2019

Parshva Enterprises IPO Date, Price, GMP, Review & Details

Incorporated in 2017, Mumbai-based Parshva Enterprises Limited is engaged in trading and wholesale business of cut & polished diamonds and gold jewelry. They buy and sell diamonds of different categories depending on fancy color, size, shape, and cut (princess-cut, heart-cut, etc.).The price of the diamond is decided based on the size and cut evaluation like poorly cut diamonds are sold at cheaper price whereas well-cut are at a premium price. They deal with natural diamonds and some of the diamonds are GIA certified as well. The company sells out diamonds to domestic clients only. In gold jewelry, Parshva Enterprises sells out gold necklaces, bangles, earrings, pendants, chains, and earrings which can be non-studded or studded with stones, diamonds, and pearls. Apart from this, the company also invest in real estate properties in Gujarat and Mumbai area and sells them for the trading gains. They are also involved in real estate broking business to deal with apartments and properties.

The competitive strengths of the company are:

1. Multiple product range

2. Good quality products

3. Market-specific products

Company Promoters:

Prashant A Vora is the promoter of the company.

Company Financials:

Summary of Financial Information (Restated)

Particulars For the year/period ended (in Rs. Lakhs)

31-Mar-19 31-Mar-18

Particulars For the year/period(d/d eefnadueltd.a s(pin) Rs. Lakhs)

Total Assets 357.93 205.41

Total Revenue 709.22 476.29

Profit After Tax 30.04 3.88

Objects of the Issue:

The objects of the Net Proceeds (as defined below) of the Issue are:

-Meeting Additional Working Capital Requirements

Parshva Enterprises IPO Details

Issue Open Jun 19, 2019 - Jun 21, 2019

Issue Type Fixed Price Issue IPO

Issue Size 810,000 Eq Shares of Rs 10

(aggregating up to Rs 3.65 Cr)

Face Value Rs 10 Per Equity Share

Issue Price Rs 45 Per Equity Share

Market Lot 3000 Shares

Min Order Quantity 3000 Shares

Listing At BSE SME

Parshva Enterprises IPO Tentative Date / Timetable

Bid/Offer Opens On Jun 19, 2019

Bid/Offer Closes On Jun 21, 2019

Finalization of Basis of Allotment Jun 27, 2019

Initiation of Refunds Jun 28, 2019

The credit of Shares to Demat Acct: Jun 28, 2019

IPO Shares Listing Date: Jul 1, 2019

Parshva Enterprises IPO Promoter Holding

Pre Issue Share Holding 100%

Post Issue Share Holding 73.09%

Company Contact Information

Parshva Enterprises Limited

811, A Wing, Jaswanti Allied Business Centre,

Ramchandra Lane Extn., Malad West,

Mumbai - 400064, Maharashtra, India

Phone: +91 22 4972 9700

Email: info@parshvaenterprises.co.in

Website: http://parshvaenterprises.co.in/

Parshva Enterprises IPO Registrar

Bigshare Services Pvt Ltd

1st Floor, Bharat Tin Works Building,

Opp. Vasant Oasis, Makwana Road,

Marol, Andheri(E), Mumbai - 400 059

Phone: +91-22-6263 8200

Email: ipo@bigshareonline.com

Website: http://www.bigshareonline.com

Conclusion / Investment Strategy

PEL has just 21 months working records. The issue is priced very aggressively. Merchant Banker has an average track record.PEL operates in a highly competitive segment. Its current issue size may take a longer time for migration to the main board. Considering all these aspects, investors may skip this issue.

Saturday, June 15, 2019

Indiabulls Consumer NCD May 2019 Public Issue Detail

Incorporated in 1994, Mumbai based Indiabulls Consumer Finance Limited (ICFL) is a non-deposit taking NBFC. The company is a 100% subsidiary of Indiabulls Ventures Limited. It also has a product called 'Indiabulls Dhani', acompletely online personal loan fulfilment offering. IBCFL also offers business loans to small and medium

businesses. The company also offers online trading services. It has a client base of over 6 lacs customers. Thecompany has a dedicated sales team of over 900 individuals in more than 18 cities. It also marketsnon-discretionary wealth management products through its subsidiaries.

The competitive strengths of the company are:

1. Pan India presence

2. Strong brand recognition

3. Wide market reach

4. In-house loan monitoring and collections teams to monitor and check NPAs

Indiabulls Consumer NCD May 2019 Detail

Issue Open May 30, 2019 - Jun 21, 2019

Security Name Indiabulls Consumer Finance Limited

Security Type Secured, Redeemable, Non-Convertible Debentures (Secured NCDs)

Issue Size (Base) Rs 1,000.00 Crores

Issue Size (Shelf) Rs 3,000.00 Crores

Issue Price Rs 1000 per NCD

Face Value Rs 1000 each NCD

Minimum Lot size 10 NCD

Market Lot 1 NCD

Listing At BSE, NSE

Credit Rating CARE AA Stable by CARE and BWR AA+ by Brickwork Ratings

Tenor 400 days/ 24 months /36 months/ 60 monthsSeries Series I to Series IX Payment Frequency Monthly and Annual Basis of Allotment Priority Basis NCD Allocation Ratio NCD's allocated in each investor category: Category (/faq/who-can-apply-in-ncd-public-issue/544/) NCD's Allocated

Category 1 (QIB) 20%

Category 2 (NII) 20%

Category 3 (HNI) 30%

Category 4 (RII) 30%

Category NCD's Reserved

Category 1 (QIB) 200,000

Category 2 (NII) 200,000

Category 3 (HNI) 300,000

Category 4 (RII) 300,000

Total NCD's 1,000,000

Coupon Rates

Coupon rates for series 1 to 9

Series 1

Series

2 Series 3

Series

5 Series 6

Series

8 Ser

Frequency

Interest

Payment

NA Annually NA Monthly Annually NA Monthly Annually NA

Tenor 400 days 24

months

mon

Coupon

Rate

NA 10.27% NA 9.95% 10.41% NA 10.13% 10.61% NA

Amount

Maturity

??1,110.10 ??1,000 ??1,215.83 ??1,000 ??1,000 ??1,345.94 ??1,000 ??1,000 ??1,6

NCD Rating Detail

The NCDs proposed to be issued under this Issue have been rated CARE AA; Stable (pronounced

as Double A; Outlook: Stable), for an amount of ??30,000 million by CARE Ratings Limited vide their

letter no. CARE/HO/RL/2018-19/4260 dated December 28, 2018. Further, they have been rated

BWR AA+ (pronounced as BWR Double A Plus) (Outlook: Stable), for an amount of ??30,000 million

by Brickwork Ratings India Private Limited vide their letter no. BWR/NCD/HO/ERC/RB/0615/2018-19

dated January 4, 2019 and instruments with this rating are considered to have high degree of

safety regarding timely servicing of financial obligations and carry very low credit risk.

Company Promoters

Indiabulls Ventures Limited is the promoter of the company.

Objects of the Issue:

The Company proposes to utilise the funds which are being raised through the Tranche II Issue,

after deducting the Tranche II Issue related expenses to the extent payable by the Company ("Net

Proceeds"), towards funding the following objects (collectively referred to herein as the "Objects"):

1. For the purpose of onward lending, financing, and for repayment of interest and principal of

existing borrowings of the Company; and

2. General corporate purposes.

Company Contact Information

Indiabulls Consumer Finance Limited

Indiabulls House,

Indiabulls Finance Centre, Senapati Bapat Marg,

Elphinstone Road, Mumbai 400 013

Phone: +91 22 6189 1000

Email: helpdesk@indiabulls.com

Website: http://www.indiabullsconsumerfinance.com/

Indiabulls Consumer NCD May 2019 Registrar

Karvy Computershare Private Limited

Karvy Registry House, 8-2-596, St. No. 1,

Banjara Hills, Hyderabad - 500 034

Andhra Pradesh, India

Phone: +91-40-23312454

Email: icfl.ncd1@karvy.com

Website: https://karisma.karvy.com

Conclusion / Investment Strategy

Although these time coupon rates are little lower than its maiden offer of February 2019, Investors may consider

medium to long term investment in this lucrative offer (with AA/Stable rating) having attractive coupon rates.

Latest Share Market News, Latest Share News, Latest Share Market Tips, Latest Share Market Videos, Latest Share Market News In Hindi, Latest Share Recommendations, Latest Stock Market News, Latest Stock Market Recommendations , Latest Stock Market News India, Latest Stock News India, Latest Stock Picks, Latest Stock Market Analysis Market Watch, Latest Stock Market Videos

Friday, June 14, 2019

More than 100 TCS employees earn more than Rs 1 crore annually.

The number of employees at Tata Consultancy ServicesNSE 0.02 % whose annual compensation topped Rs 1 crore has crossed 100 in FY19, data accessed by ET shows. Nearly a quarter of these employees began their careers with the country’s largest IT company.

In FY17, TCS had 91 crorepatis, which jumped to 103 in FY19, excluding the compensation of CEO Rajesh Gopinathan and

COO NG Subramaniam. The data also excludes the salaries of executives based outside India. In comparison, InfosysNSE -0.30 % had over 60 employees earning salaries over Rs 1.02 crore. Unlike Infosys, TCS’ compensation does not include a stock component, which strips out a significant amount of variability.

Debashis Ghosh, head of TCS’ life sciences, healthcare and public services business earned over Rs 4.7 crore; Krishnan Ramanujam, head of business and technology services, made more than Rs 4.1 crore, and K Krithivasan, head of the company’s banking, financial services and insurance business, earned over Rs 4.3 crore. K Ananth Krishnan, the company’s chief technology officer, earned more than Rs 3.5 crore. Pratik Pal, the former head of retail and consumer products, got over Rs 4.3 crore in compensation. Pal has since moved on to Tata Sons to work on the group’s digital initiatives, ET reported earlier. “The data above comprises salary, allowances, cash incentive, the monetary value of perquisites as per Income Tax Rules and company’s contribution to provident and superannuation fund,” the annexure to the director’s report said. TCS does not publish this in its annual report. The company did not respond to a request seeking comment.

Interestingly, the oldest employee who earned a salary of over Rs 1 crore in FY19 was the 72-year-old Barindra Sanyal, who is vice president for finance.

Analysts say part of the reason for TCS’ success has been the stability of its senior leadership and its ability to give people leadership roles without losing them to rivals. “For senior executives, TCS has a very good retention rate. They have created paths for career progression so that people don’t feel the need to leave the company and they also have a more decentralized leadership style,” an analyst with a Mumbai-based brokerage said.

Last year, TCS rejigged its services units to give close to 200 senior executives control over the business to meet quarterly targets and freed up top management to meet longer-term goals.

The CEO, presidents and executive vice presidents at the company focus on creating three- and five-year strategy plans, which could include plans to enter new markets and service areas focused on different customers.

TCS Employees Salaries, TCS Employees Tata Consultancy Services, Debashish Ghosh, Rajesh Gopinathan, Infosys, Tata Group, Tata consultancy services,ratan tata,tata consultancy services ltd,TCS share,Tata consultancy services share,Tata consultancy services ltd share,tata consultancy,tata consultancy services interview,Tata consultancy services campus interview,Tata consultancy services interview rounds,tata consultancy services ltd stock analysis,tata consultancy services interview process,tata consultancy services interview pattern

Thursday, June 13, 2019

Anand Rayons IPO Date, Price, GMP, Review & Details

Incorporated in 1987, Anand Rayons Limited was an idea of MrGokul Bakshi. It is engaged in trading of yarn and value-added yarns including polyester filament yarns, nylon yarns, fancy yarns, and dope dyed yarns. Initially, the company had only one dealer for the polyester yarn that is Reliance Industries Limited to trade in and around Surat, Gujarat. Now, the company has also extended the dealership network with JCT Limited for Nylon Yarn, and

Indorama Synthetics India Limited, Filatex India Limited and Garden Silk Mills Limited for Polyester Yarn. The yarns traded by the company has wide application in the weaving of sarees, yarn dyeing, Elastic tapes, carpets, and dress & shirting materials. As the company is trading in and around Surat only, it is planning to expand yarn trading business in other states such as Maharashtra, Delhi, Karnataka, and Uttar Pradesh as well. The R&D team of the company is also working on twisted yarn, Sheath- Core yarn, Bi-Shrinkage yarn for GEOtextiles to expand the business.

The competitive strengths of the company are:

1. Specialization in trading of yarns and value-added yarns.

2. Strong dealership with Reliance Industries Ltd for 31+ years.

3. A sound relationship with spinners & customers.

Company Promoters:

Mr. Anand Bakshi is the promoter of the company.

Company Financials:

Summary of financial Information (Restated)

Particulars For the year/period ended (in Rs. Lakhs)

31-Jan-19 31-Mar-18 31-Dec-17 31-Mar-16

Total Assets 6,103.46 5,942.08 5,809.05 3,796.06

Total Revenue 23,176.44 25,959.08 27,062.38 21,992.23

Profit After Tax 172.41 145.14 104.70 45.73

Objects of the Issue:

The objects of the Issue are:

1. Incremental Working capital requirements

2. General Corporate Purpose,

3. Meeting Public Issue Expenses.

Anand Rayons IPO Details

Issue Open Jun 18, 2019 - Jun 24, 2019

Issue Type Fixed Price Issue IPO

Issue Size 4,688,000 Eq Shares of Rs 10

(aggregating up to Rs 12.66 Cr)

Face Value Rs 10 Per Equity Share

Issue Price Rs 27 Per Equity Share

Market Lot 4000 Shares

Min Order Quantity 4000 Shares

Listing At BSE SME

Anand Rayons IPO Registrar

Bigshare Services Pvt Ltd

1st Floor, Bharat Tin Works Building,

Opp. Vasant Oasis, Makwana Road,

Marol, Andheri(E), Mumbai - 400 059

Phone: +91-22-6263 8200

Email: ipo@bigshareonline.com

Website: http://www.bigshareonline.com

Company Contact Information

Anand Rayons Limited

305-306, Jay Sagar Complex

Opp. Sub Jail, Khatodra,

Surat-395002 Gujarat

Phone: 0261-2635521

Email: anandrayonsltd@gmail.com

Website: http://www.anandrayons.com

Conclusion / Investment strategy

The textile segment is not fancied by investors in the given scenario. The issue is priced very

aggressively Guiness group has a topsy-turvy background Considering all these facts it is better

aggressively. Guiness group has a topsy turvy background. Considering all these facts, it is better

to skip this issue.

Wednesday, June 12, 2019

Meera Industries FPO Date, Price, GMP, Review & Details

Incorporated in 2006, Meera Industries Limited is engaged in manufacturing of textile machines such as

winding, twisting, heat setting and cabling machines. In addition, the high-performance machines are also designed, developed and sold by the company to other textile manufacturing and processing units. They also

provide a testing facility and assistance after sales to maintain a healthy relationship with customers.

The company has its own yarn twisting division which was started in the year 2017-18 to process and sell the yarn. It also exports textile machinery products in South America, Europe, America, Africa, and Asia continents. It has a wholly owned subsidiary named Meera Industries USA LLC located in the State of Northern Carolina to supply products in Canada, the USA and other South American countries.

Meera Industries' manufacturing unit is located at Surat, Gujarat to produce heatsetting, winding, and yarn twisting machine. An R&D Center approved by DSIR (Department of Scientific and Industrial Research) is also located in this manufacturing unit.

The competitive strengths of the company are:

1. Cost effective products

2. Timely order execution

3. Manufacturing unit at a prime location

4. A balance sheet with zero debt

5. In house manufacturing, and R&D unit

Company Promoters:

Mr. Dharmesh V. Desai and Mrs. Bijal D. Desai are the promoters of the company.

Company Financials:

Summary of financial Information (Restated)

Particulars For the year/period ended (in Rs. Lakhs)

Particulars For the year/period ended 31-Dec-19 31-Ma (ri-n1 8Rs. Lakhs)

Total Assets 2,166.42 1,468.14

Total Revenue 3,558.41 2,149.66

Profit After Tax 494.55 240.80

Objects of the Issue:

The Objects of the Issue are to:

(a) Fund expansion of manufacturing facilities at Sachin, Surat; and

(b) Fund expenditure for General Corporate Purposes.

Meera Industries Ltd Stock Quote & Charts

7D 15D 1M 3M 6M 1Y 18M 2Y

Meera Industries FPO Details

Issue Open Jun 13, 2019 - Jun 18, 2019

Issue Type Fixed Price Issue FPO

Issue Size 522,000 Eq Shares of Rs 10

(aggregating up to Rs 11.75 Cr)

Face Value Rs 10 Per Equity Share

Issue Price Rs 225 Per Equity Share

Market Lot 500 Shares

Min Order Quantity 500 Shares

Listing At BSE SME

Meera Industries FPO Tentative Date / Timetable

Bid/Offer Opens On Jun 13, 2019

Bid/Offer Closes On Jun 18, 2019

Finalisation of Basis of Allotment Jun 21, 2019

Initiation of Refunds Jun 24, 2019

Credit of Shares to Demat Acct: Jun 25, 2019

IPO Shares Listing Date: Jun 26, 2019

Company Contact Information

Meera Industries Limited

2126, Road No. 2,

GIDC, Sachin,

Surat, Gujarat - 394230

Phone: + 91 261 2399114

Email: info@meeraind.com

Website: https://www.meeraind.com

Meera Industries FPO Registrar

Karvy Computershare Private Limited

Karvy Registry House, 8-2-596, St. No. 1,

Banjara Hills, Hyderabad - 500 034

Andhra Pradesh, India

Phone: +91-40-23312454

Email: einward.ris@karvy.com

Website: https://karisma.karvy.com/

Conclusion / Investment Strategy

Based on its maiden IPO price, it has given attractive returns in the long term and has posted growth in top and bottom lines.However, current FPO is at a higher price than the last traded price of Rs. 208.65. To sail through this FPO, the market operation is not ruled out to lure investors. Hence cash surplus risk savvy investors may consider investment for long term at their own

risk.

sensex,nifty,sensex today,bse sensex,sensex all time high,sensex news,sensex hits high,nifty and nifty bank,bank nifty weekly,nifty weekly,scan for 52 week highs,stocks and shares,stock market,sensex live updates,sensex live chart,sensex live news today,sensex live today,sensex makes history,nifty news,sensex live market,sensex chart,business and finance,nse nifty,nifty live,futures and options

Wednesday, June 5, 2019

Sudarshan Pharma IPO Date, Price, GMP, Review & Details.

Incorporated in 2008, Mumbai based Sudarshan Pharma Industries Limited (SPIL) has a contract manufacturing facility to source and supply generic formulations. It is also engaged in import & export activities, and supply of specialty chemicals, API (Active Pharmaceutical Ingredients), and Intermediates. Based on clients' specifications and requirements, they outsource the manufacturing facility from the suppliers in India and abroad.

The generic products supplied by the company have a wide application in paint, food, pharma, and adhesive industry. The company is involved in a contract manufacturing facility, supply and outsource of medicines and pharma formulation to hospitals, NGO, government and healthcare institutes. SPIL has 50 pharma formulations which are supplied under the brand name in the form of tablets, ointment, capsules, and injectable.

The company has its own sales force and distribution network in 5 states for ethical marketing of pharmaceutical formulation & products under the brand name in Indian and international markets. It also offers formulation development and QC services and provides customised solutions.

The competitive strengths of the company are:

1. Customer-centric and order driven business model

2. Wide range of product offerings

3. Contract manufacturing facility arrangements

4. Strong distribution, marketing and sales network

5. Diversified business operations

Company Promoters:

Mr. Hemal V. Mehta and Mr. Sachin V. Mehta are the promoters of the company.

Company Financials:

Summary of financial Information (Restated)

Particulars For the year/period ended (in Rs. Lakhs)

31-Mar-19 31-Mar-18 31-Mar-17 31-Mar-16

2/2019 Sudarshan Pharma IPO Date, Price, GMP, Review & Details

https://www.chittorgarh.com/ipo/sudarshan-pharma-ipo/992/ 2/10

Particulars For the year/perio(d/d eefnadueltd.a s(pin) Rs. Lakhs)

Total Assets 4,998.71 3,096.37 1,992.93 827.24

Total Revenue 14,001.96 8,976.43 5,551.72 3,794.33

Profit After Tax 234.79 73.98 15.63 9.27

Objects of the Issue:

The Net Proceeds from the Issue are proposed to be utilized by the Company for the following objects:

1) To set up a dedicated manufacturing facility for Pharmaceutical Business;

2) Distribution and Warehousing Centre's & Purchase of Corporate Office;

3) Additional Working Capital;

4) General Corporate Expenses; and

5) To meet the expenses of the Issue.

Sudarshan Pharma IPO Details

Issue Open

Issue Type Fixed Price Issue IPO

Issue Size 3,440,000 Eq Shares of Rs 10

(aggregating up to Rs 25.80 Cr)

Face Value Rs 10 Per Equity Share

Issue Price Rs 75 Per Equity Share

Market Lot 1600 Shares

Min Order Quantity 1600 Shares

Listing At NSE SME

Sudarshan Pharma IPO Promoter Holding

Pre Issue Share Holding 89.29%

Post Issue Share Holding 65.63%

Company Contact Information

Sudarshan Pharma Industries Limited

301, 3rd Floor, Aura Biplex,

Above Kalyan Jewellers, S V Road,

Borivali (West), Mumbai - 400 092,

Phone: +91 22 242221111

Email: compliance.spil@gmail.com

Website: http://www.sudarshanpharma.com

Sudarshan Pharma IPO Registrar

Karvy Computershare Private Limited

Karvy Registry House, 8-2-596, St. No. 1,

Banjara Hills, Hyderabad - 500 034

Andhra Pradesh, India

Phone: +91-40-23312454

Email: einward.ris@karvy.com

Website: https://karisma.karvy.com

Techsuvichar

Thursday, June 20, 2019

Earum IPO Date, Price, GMP, Review & Details

Monday, June 17, 2019

Parshva Enterprises IPO Date, Price, GMP, Review & Details

Saturday, June 15, 2019

Indiabulls Consumer NCD May 2019 Public Issue Detail

Friday, June 14, 2019

More than 100 TCS employees earn more than Rs 1 crore annually.

Thursday, June 13, 2019

Anand Rayons IPO Date, Price, GMP, Review & Details

Wednesday, June 12, 2019

Meera Industries FPO Date, Price, GMP, Review & Details

Wednesday, June 5, 2019

Sudarshan Pharma IPO Date, Price, GMP, Review & Details.

Adani group ne kyun band kiya 34900 Crore ka Project Band

Report Abuse

Labels